Gene expression of semaphorin-3A, semaphorin-7A, neuropilin-1, plexin-C1, and β1 integrin in treated-multiple sclerosis patients.

Shima ShapooriGhasem MosayebiMohsen Ebrahimi MonfaredAli GhazaviBehzad KhansarinejadIman FarahaniAli Ganji

Published in: Neurological research (2020)

Our findings confirm that the presence of Sema3A, Sema7A, and their receptors can play critical roles in the treatment of MS patients. Therefore, they can be potential target molecules for MS treatment in the future.

Keyphrases

multiple sclerosis
gene expression
newly diagnosed
ejection fraction
mass spectrometry
prognostic factors
climate change
current status
patient reported